Doctor concerned with health care law

Breaking news and expert analysis on legal and compliance issues

[Back To Home][Back To Archives]

From Health Law Daily, January 24, 2018

Senate confirms Alex Azar as HHS Secretary

By Kathryn S. Beard, J.D.

By a vote of 55 to 43, the Senate confirmed Alex M. Azar II, a former pharmaceutical executive, as HHS Secretary on January 24, 2017. Acting Secretary Eric Hargan, the designated temporary replacement for former Secretary Tom Price, M.D., will return to his role as Deputy Secretary, for which he was confirmed in October 2017. The vote was mostly split on party lines, though five Democrats joined their GOP colleagues in voting yea and Sen. Rand Paul (R-Ky) voted nay. Sens. McCain (R-Ariz) and Corker (R-Tenn) did not vote.

Following Price’s resignation, President Trump nominated Azar, who previously served as HHS Deputy Secretary and General Counsel, and later led Eli Lilly’s United States division (see Former pharmaceutical executive Azar nominated to fill HHS Secretary role, November 13, 2017). His background led to questions about the cost of prescription drugs, as well as concerns related to Medicaid and the Affordable Care Act, during his confirmation hearing (see Azar fields questions about drug prices, Medicaid during Senate nom hearing, January 10, 2018).

Price, a former member of the House of Representatives, resigned in September 2017 following a scandal related to his use of private airplanes to conduct HHS business. President Trump initially designated Don J. Wright, Deputy Assistant Secretary for Health and Director of the Office of Disease Prevention and Health Promotion, as Acting HHS Secretary (see There’s a new doctor in town: Price no longer HHS Secretary, Wright filling in, October 2, 2017); subsequently, Hargan was designated for the role (see Newly confirmed HHS Deputy Secretary Hargan takes over from Wright as Acting Secretary, October 11, 2017). Lead-in. TEXT.

MainStory: TopStory NewsStory AgencyNews DrugNews WhiteHouseNews SenateNews CMSNews FDCActNews EligibilityNews PrescriptionDrugNews FedTracker HealthCare LifeSciences

Back to Top

Health Law Daily

Introducing Wolters Kluwer Health Law Daily — a daily reporting service created by attorneys, for attorneys — providing same-day coverage of breaking news, court decisions, legislation, and regulatory activity.

A complete daily report of the news that affects your world

  • View full summaries of federal and state court decisions.
  • Access full text of legislative and regulatory developments.
  • Customize your daily email by topic and/or jurisdiction.
  • Search archives for stories of interest.

Not just news — the right news

  • Get expert analysis written by subject matter specialists—created by attorneys for attorneys.
  • Track law firms and organizations in the headlines with our new “Who’s in the News” feature.
  • Promote your firm with our new reprint policy.

24/7 access for a 24/7 world

  • Forward information with special copyright permissions, encouraging collaboration between counsel and colleagues.
  • Save time with mobile apps for your BlackBerry, iPhone, iPad, Android, or Kindle.
  • Access all links from any mobile device without being prompted for user name and password.